Aton acquires US rights to Parkinson's drug from BMS
This article was originally published in Scrip
Executive Summary
Aton Pharma has acquired US marketing rights to the Parkinson's disease-indicated drug Lodosyn (carbidopa) from Bristol-Myers Squibb.